About · Contact us · Terms of use · Dr. T
Alzheimer References
- van Rensberg, S.J., Daniels, W.M., Potocnik, F.C., et al. A new model for the pathophysiology of Alzheimer's disease. Aluminum toxicity us exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin. S Afr J Med87(9):1111-1115;1997.
- Weiner, M.A., Evidence points to aluminum's link with Alzheimer's disease. Townsend Letter for Doctors 124:1103; 1993.
- Birchell, J.D., Chappel, J.S., Aluminum, Chemical Physiology and Alzheimer's Disease. Lancet 2(8618):1008-1010; 1988.
- Faßender, K., Mielke, O., Bertsch, T. et al. Homocysteine in cerebral macroangiography and microangiography. Lancet 353:1586-1587; 1999.
- Clarke, R., Smith, A.D., Jobst, K.A., et al. Folate, Vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 55:1449-55; 1998.
- Müller, T., Werne, B., Fowler, W., et al. Nigral endothelial dysfunction and Parkinson's disease. Lancet 354:126-127; 1999.
- Smulders, Y.M., de Man, A.M.E., Stehouwer, C.D.A. Trimethoprim and fasting homocysteine Lancet 352: 1827-1828; 1998.
- Floyd, R.A. Neuroinflammatory processes are important in neurodegenerative disease: A hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radical Biology and Medicine 26(9/10):1346-55; 1999.
- Newman, P.E., Could diet be used to reduce the risk of developing Alzheimer's disease? Med Hypothesis 50:335-37; 1998.
- Sano, M., Ernesto, C., Thomas, R.G., et al. A controlled trial of selegeline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New Engl J Med 336:1216-22;1997.
- Janetsky, B., Reichmann, H., Youdim, M.B.H. Iron and Oxidative damage in neurodegenerative diseases, in Mitochondria and Free Radicals in Neurodegenerative Diseases. Beal, M.F. (ed) New York, Wiley-Liss Pub. 1997.
- Pahan, J., Sheikh, F.G., Namboodiri, A.M.S., N-acetylcysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat perionel macrophages, C6 glial cells and astrocytes. Free Radical Biology and Medicine 24(1):39-48; 1997.
- Stao, Y., Asoh, T., Oizumi, K. High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 23(6):555-557; 1998.
- Shults, C.W., Beal, M.F., Fontaine, K., et al. Absorption, tolerability and effects on mitochondrial activity of oral coenzyme Q10 in Parkinson's patients. Neurology 50:793-795; 1998.
- Birkmayer, J.G.D. Coenzyme Nicotinamide Adenine Dinucleotide-New Therapeutic Approach for Improving Dementia in Alzheimer Type. Ann Clin and Lab Science 26(1):1-9;1996.
- Thal, L.J., Carta, A., Clarke, W.R., et al. A 1-year multicenter, placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 47:705-711; 1996.
- Crook, T.H., Tinklenberg, J., Yesavage, J. Effects of phosphatidylserine in age-associated memory impairment. Neurology 47:705-711; 1996.
- Clarke, R., Smith, A.D., Jobst, K.A. et al. Folate, vitamin B-12, and serum total homocysteine levelsin confirmed Alzheimer's disease. Arch Neurol 55:1449-55; 1998.





